NICOLE CIFFONE: Open Payments
NPI 1750369500 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$62,731 in 150 payments from 7 companies in 2025. Trend: 2023 $17,626 · 2024 $60,312 · 2025 $62,731
Speaker / faculty: $46,730Travel & lodging: $9,823Consulting: $4,343Food & beverage: $1,835
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 117 | $49,766 |
| Regeneron Healthcare Solutions, Inc. | 16 | $7,068 |
| Amgen Inc. | 10 | $4,186 |
| Novartis Pharmaceuticals Corporation | 2 | $1,142 |
| Ionis Pharmaceuticals, Inc. | 2 | $408 |
| Kestra Medical Technology Services, Inc. | 1 | $120 |
| Esperion Therapeutics, Inc. | 2 | $42 |
Products named: ZEPBOUND, MOUNJARO, EVKEEZA, REPATHA, LEQVIO, TRYNGOLZA, Assure WCD, NEXLETOL.
Industry payments across AZ — which companies pay providers there.
